These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1153111)

  • 21. Treatment of aplastic anemia.
    Gale RP
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):117-26. PubMed ID: 3914736
    [No Abstract]   [Full Text] [Related]  

  • 22. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recovery from aplastic anemia after treatment with cyclophosphamide.
    Baran DT; Griner PF; Klemperer MR
    N Engl J Med; 1976 Dec; 295(27):1522-3. PubMed ID: 995159
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pathogenesis and treatment of aplastic anemia. Recent advances].
    Nomura T
    Nihon Ika Daigaku Zasshi; 1985 Dec; 52(6):613-23. PubMed ID: 3912403
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of severe aplastic anemia: a prospective study of antilymphocyte globulin versus bone marrow transplantation.
    Speck B; Gratwohl A; Nissen C; Osterwalder B; Signer E; Jeannet M
    Prog Clin Biol Res; 1984; 148():249-58. PubMed ID: 6379663
    [No Abstract]   [Full Text] [Related]  

  • 26. [Chronic extemporal aregenerative anemia as a possible transition form between primary global bone-marrow aplasia and chronic idiopathic erythroblastopenia not associated with thymoma. Clinical contribution].
    Gualdi CN
    Minerva Med; 1977 Mar; 68(16):1057-60. PubMed ID: 854221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of aplastic anaemia: first do no harm.
    Marsh JC
    Lancet; 2000 Nov; 356(9241):1536-7. PubMed ID: 11075760
    [No Abstract]   [Full Text] [Related]  

  • 28. Severe aplastic anemia with hot pockets following daily Ecstasy ingestion.
    Richman J; Ferber A
    Am J Hematol; 2008 Apr; 83(4):321-2. PubMed ID: 17994570
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of severe aplastic anemia with a prolonged course of anti-thymocyte globulin.
    Cosimi AB; Peters C; Harmon D; Ellman L
    Transplant Proc; 1982 Dec; 14(4):761-4. PubMed ID: 6984802
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antilymphocyte globulin combining with cyclosporine A in the treatment of severe aplastic anemia].
    Zheng Y; Chu Y; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 1999 Apr; 20(4):175-7. PubMed ID: 11601221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remission in pure red blood cell aplasia following immunosuppressive therapy.
    Zucker S; Likhite VV; Weintraub LR; Crosby WH
    Arch Intern Med; 1974 Aug; 134(2):317-20. PubMed ID: 4602049
    [No Abstract]   [Full Text] [Related]  

  • 32. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment.
    Manz CY; Nissen C; Wodnar-Filipowicz A
    Am J Hematol; 1996 Aug; 52(4):264-74. PubMed ID: 8701944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful immunosuppressive treatment of erythroid aplasia appearing after thymectomy.
    Safdar SH; Krantz SB; Brown EB
    Br J Haematol; 1970 Oct; 19(4):435-43. PubMed ID: 5312272
    [No Abstract]   [Full Text] [Related]  

  • 34. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin.
    Krantz SB
    Blood; 1972 Mar; 39(3):347-60. PubMed ID: 4110433
    [No Abstract]   [Full Text] [Related]  

  • 36. [Our experience in the treatment of severe bone marrow aplasia].
    Zabala P; Díez JL; Cabrera R; Sanjuán I; Barbolla L; Fernández MN
    Sangre (Barc); 1984; 29(5):868-71. PubMed ID: 6395405
    [No Abstract]   [Full Text] [Related]  

  • 37. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
    George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
    Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesalazine-induced aplastic anemia.
    Wiesen A; Wiesen J; Limaye S; Kaushik N
    Am J Gastroenterol; 2009 Apr; 104(4):1063. PubMed ID: 19259075
    [No Abstract]   [Full Text] [Related]  

  • 39. Aplastic anemia: which treatment?
    Abkowitz JL
    Ann Intern Med; 2001 Oct; 135(7):524-6. PubMed ID: 11578156
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
    Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
    Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.